SHIN SUNG TK CO LIMITED ENTER HEALTH CARE MARKET IN INDIA WITH JOINT VENTURE WITH PERE-D BIZ UNDER MAKE IN INDIA


PTI | New Delhi | Updated: 08-04-2019 16:40 IST | Created: 08-04-2019 16:40 IST
SHIN SUNG TK CO LIMITED ENTER HEALTH CARE MARKET IN INDIA WITH JOINT VENTURE WITH PERE-D BIZ UNDER MAKE IN INDIA

New Delhi, India, April 8, 2019 : SHIN SUNG TK CO LIMITED with a revenue of 2100 Million, of South Korea in Joint Venture with Père-d-biz Consulting entered the healthcare segment in India under MAKE IN INDIA program of honorable Prime Minister Shri Modi Ji, and planning to invest approximately 40 million and more in different phases in India, as per the requirement and going to generate a large number of the employment across India in R&D, Sales & Marketing, Pre-sales & post-sales support and Software Development area.

Mr. EUN-SUAB LIM - President of SHIN SUNG TK CO LIMITED said that the product IRinger, is a result of very Intense R&;D done in the Research and Development Institute of SHIN SUNG in South Korea. We are pleased to inform that IRinger product is newly invented and has obtained 5 patents and Awaiting for 5 patents allotment, internationally. There were many countries running after taking this Opportunity to manufacture iringer in their respective countries, but with the help of Indian Embassy in Republic of Korea, INDIA INVEST and KOREA PLUS team a Joint Venture agreement Was signed between SHIN SUNG TK CO LIMITED and Père-d-biz Consulting on 1st April 2019, to Manufacture the product in India to address the indigenous and global demand.

Mr. Ramneek said, that this product IRinger is internationally recognized invention and for future expansion many venture capitalists have started approaching the company for investment to take this product further in whole globe as a revolution in healthcare industry.

"We are doing further research and as a road map of the product, we are going to expand multiple usage of the IRinger to benefit people at large across the globe" said Mr. LIM. We are very proud of Indian Embassy in Republic of Korea, The Korea Plus team of India Invest which leads the investment promotion and startup said Mr. Vineet Agarwal.

IRinger will report and manage the setup of the speed of drops as prescribed by doctor and specific to the medicine used for IV. In particular, IRinger provides alarm through smart call (automatic call) in case of abnormality and receives favourable response from hospital nurses. In April, last year, company won the Excellence Gold Award at the International Invention Exhibition in Geneva, Switzerland. Mr. Ramneek Kumar Talwar mentioned that under existing IV infusion management system we have many challenges for Doctors, Nursing Staff and attendants. IRinger will remove all such challenges and provide better time, money, patient management, by over-ruling the current risk areas. PWR

PWR

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback